Geratherm Medical AG

Earnings Release • Nov 4, 2009

News Details

Ad-hoc | 4 November 2009 10:17

Geratherm Medical AG: positive development continues

Geratherm Medical AG / Quarter Results

04.11.2009

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

DGAP-Adhoc: Geratherm Medical - positive development continues

Ad-hoc announcement pursuant to Section 15 WpHG (German Securities Trading
Act) transmitted by DGAP - a company of the Equity Story AG. The issuer is
responsible for the contents of this announcement.

Preliminary business numbers for the 3rd quarter 2009; and as per
30/09/2009

• Turnover mEUR 3.8 + 45%; mEUR 10.2 + 38%

• EBITDA kEUR 716 + 211%; kEUR 1,832 + 180%

• EBIT kEUR 619 + 286%; kEUR 1,583 + 271%

• Period earnings kEUR 572 + 60%; kEUR 1,483 + 127%

• Earnings per share 13 cents; 33 Cents

Geschwenda, 4th November 2009 - The positive business development of
Geratherm Medical continued also in the 3rd quarter. More or less all
product areas recorded extraordinarily high growth rates.

The demand for Geratherm products is currently significantly higher than
our delivery possibilities. We are stocking up the capacity at the moment.
As of December 2009, we will have tripled our production capacities as
compared to the year 2008. Thus, we expect strong growth also for the 4th
quarter of 2009. The additional capacity use will be reflected in turnover
and earnings mainly in 2010.

The publication of the detailed business numbers for the 3rd quarter of
2009 is scheduled for

19th November 2009.

Short company profile

Geratherm Medical is an internationally operating medical products
enterprise with the business areas Health Care Diagnostik, Medical Warming
Systems, Cardio/Stroke and Respiratory.

Our company's roots are in temperature measurement in the medical sphere.
In this business area we offer a broad spectrum of products, most of which
have unique selling points. We supply our customers/patients with
high-quality products ranging from thermometers to complex warming systems
for use in the operating theatre and by emergency rescue services. In the
Cardio business area we concentrate on the development of products for the
detection of atrial fibrillation as a measure to prevent strokes. The
Respiratory segment develops and markets products for the assessment of
pulmonary function.

In all mainly business areas, Geratherm has patent-protected basic
technologies at its disposal. We regard ourselves as a research-based
medical products company with a clear focus on medical diagnostic devices
that generate vital data.

Geratherm shares have been listed in the Prime Standard segment of the
Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues
to be represented in the German Entrepreneurial Index and in the German
Health-Care Index.

Geratherm Medical AG, Investor Relations

Fahrenheitstraße 1, 98716 Geschwenda

Tel. +49 (0)36205/98 111, E-Mail: info@geratherm.com www.geratherm.com

Emittent: Geratherm Medical AG, Fahrenheitstraße 1, 98716 Geschwenda
Deutschland

Tel. 036205/98 111 Fax: 036205/98 115

ISIN : DE 000 549 562 6

WKN : 549 562

Börsen : Frankfurter Wertpapierbörse /Geregelter Markt/Prime Standard

Börse: Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, München,
Stuttgart

Ende der Mitteilung -

04.11.2009 Financial News transmitted by DGAP

---

Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
98716 Geschwenda
Deutschland
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: info@geratherm.com
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Hamburg, Stuttgart

End of News DGAP News-Service

---